A palliative care model and conceptual approach suited to clinical malignant haematology
The term haematological malignancy refers to a collection of heterogeneous neoplasms with significant variation in presentation, prognosis and management. Survival is vastly different between people with early-stage Hodgkin lymphoma versus elderly people diagnosed with acute myeloid leukaemia. Even within a specific disease type, substantial variation exists in treatment and prognosis that is dependent on characteristics of the individual (i.e. age, comorbidities) and the disease (i.e. cytogenetics, method of development).
For many people with a haematological malignancy, aggressive treatment provides the only possible hope of cure, but also carries the risk of serious complications and death. Patients who receive conservative supportive therapy are also at risk of deterioration due to bone marrow suppression. People with a haematological malignancy often experience episodes of sudden and acute deterioration related to the treatment or the underlying disease. 1, 2 However, it is not uncommon for these patients to recover from episodes of 'near-to-death' deterioration. 1, 2 This erratic illness trajectory makes predicting survival near the end of life difficult for clinicians. 2 Hence, people with a haematological malignancy often experience a swift change in their goals of care, leaving little time for planning and preparing for death. 1, 2 A growing body of evidence highlights that people with a haematological malignancy often receive suboptimal standards of palliative care. 2 Challenges integrating palliative care in the haematology setting have largely been attributed to the unpredictable illness trajectory these patients often experience and lack of knowledge and understanding of palliative care among health care professionals. 1,2 Although palliative care is recommended to be integrated (and known to lead to benefits) early in the illness trajectory for people with a life-threatening illness, 3 many haematologists still perceive palliative care as end-of-life care. 4 Palliative care is integrated later and less often for people with a haematological malignancy compared to those with other types of cancer. 2 There is a gap in knowledge and variation in practice around how and when to provide best practice palliative care for people with a haematological malignancy. 2 In this opinion piece, we discuss a palliative care model and conceptual approach that are well suited to clinical malignant haematology and can lead to best practice palliative and end-of-life care for this unique population.
Palliative care models have evolved and advanced over time. The original hospice model (the sequential model) transitioned to the concurrent model, allowing for earlier integration of palliative care alongside care of life-prolonging intent. 5 In this model, care of palliative intent gradually increases over time. This may be more suited to people dying of many of the non-haematological malignancies where deterioration is often slow and predictable. A modified palliative care model was developed by Chung et al. 6 for recipients of haematopoietic stem cell transplantation, where palliative care is introduced from the diagnosis of a haematological malignancy and provided alongside care of curative or life-prolonging intent. However, instead of gradually increasing, care with palliative intent fluctuates depending on the clinical scenario (including holistic issues) and preferences of patients and their families. In this model, health care professionals carefully balance providing care that aims to relieve the severity of an illness without curing the underlying disease, with aggressive, curative care. 6 A limitation of the sequential model, concurrent model and Chung and colleagues' model is that the end point of care for the patient is depicted in death. In the case of some people with a haematological malignancy who have palliative needs, the end point may be remission or cure. We propose a slight modification to the Chung and colleagues' model (displayed in Figure 1 ). Palliative care is still integrated from diagnosis and tailored around the individual's needs, but can lead to death and bereavement care (blue line on the bottom) or cure and survivorship care (green line on the top). This model demonstrates the evolution of the palliative care model from terminal care to individualised care that is responsive to patients' needs and unpredictable illness trajectories. The model is appropriate for those who have slow, progressive incurable disease and those with acute aggressive disease who will undergo curative treatment with a signficant chance of treatment-related mortality.
The successful application of the model requires patients and their families to be fully informed and play an active role in decision making. This requires skilled and sensitive communication from health care professionals that is tailored to the individual patients and their families Invited Editorials and takes into account the vastly different illness trajectories experienced by people with a haematological malignancy. A simple and practical conceptual approach to explaining palliative care is required to facilitate understanding, acceptance and active participation with early palliative care integration for people who may also have a chance of cure or long-term remission.
A conceptual model developed by Bruera and Hui 7 for integrating palliative care at cancer centres is the perfect accompaniment for the proposed updated model displayed in Figure 1 . This conceptual model is aptly titled 'the goals of car(e)', and a car is used as an analogy for a patient's cancer journey. 7 Bruera and Hui's 7 model proposes that a risk management approach to introducing palliative care to patients and their families, (and health care workers), early in the illness trajectory can still be compatible with a realistic and hopeful attitude. In the goals of care(e) model, supportive and palliative care are introduced and explained in the same way as an insurance policy to protect the car against any unwanted events that occur during the journey. It does not mean that a person with a life-threatening cancer has to give up hope or abandon the goal of cure or life prolongation. Rather, it encourages them to take precautions for the possibility of distressing symptoms, disease recurrence and death.
Supportive and palliative care can prepare patients and their families for challenges that lie ahead, enhance physical and emotional care throughout the illness trajectory and provide safety and comfort if unwanted events occur. The authors explain that being unrealistic and not taking precautions can expose patients and their families to unnecessary risk and discomfort. 7 Bruera and Hui 7 explain that this conceptual model is useful in discussions with health care professionals and patients regarding goals of care, the role of palliative care and advance care planning. The model clarifies that palliative care is not necessarily always end-of-life care. 8 Haematologists often mistake palliative care for end-oflife care and have reported issues around trust, control and differences in goals of care as barriers to accessing specialist palliative care services. 4 The modified palliative care model (displayed in Figure 1 ) and Bruera and Hui's conceptual model to palliative care integration may help to address these issues by providing approaches that are well-suited to the unique illness trajectory of people with a haematological malignancy.
The Bruera and Hui's 7 model shares a similar concept to 'rainy day thinking' or the 'hope for the best … prepare for the rest' approach where identifying people at risk of dying is believed to improve end-of-life care. 8 The metaphor is to take your umbrella with you when you leave the house if there is high chance of rain. This risk management approach may be the future of palliative care integration in the haematology setting and beyond as advances in medicine lead to more prognostic uncertainty. This simple, practical approach combined with modern-day models of palliative care will allow for earlier integration of palliative care and anticipatory care planning. This approach is likely to give many people with a haematological malignancy better quality of life, more control over the time they have remaining and the best death possible.
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